CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know

Similar documents
Transfusion and Blood Conservation

Understanding the Cardiopulmonary Bypass Machine and Its Tubing

Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease

August, 2015 STATE MEDICAL FACULTY OF WEST BENGAL. Preliminary Examinations for Diploma in Perfusion Technology : DPfT. Paper I ANATOMY & PHYSIOLOGY

Cardiac anaesthesia. Simon May

No Disclosures. Objectives. Objectives 10/10/2018

A Study of Prior Cases

PROTOCOLS and GUIDELINES for PEDIATRIC PERFUSION

Intra-operative Echocardiography: When to Go Back on Pump

Cardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center

10/10/2018. Disclosures. Introduction (II) Introduction (I) The authors have no disclosures

Perfusion for Repair of Aneurysms of the Transverse Aortic Arch

Navigating the Dichotomies Between Literature and Your Clinical Practice

CPB pump flow, and effective Flow in patient. 1

Patient. Venous reservoir. Hemofilter. Heat exchanger. Pump mode. Oxygenator. CHAPTER II - Extracorporeal Circulation (ECC)

ECMO vs. CPB for Intraoperative Support: How do you Choose?

Going on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia

Introduction to Cardiopulmonary Bypass. Syllabus for TSDA Boot Camp Ron Angona, Perfusionist University of Rochester Medical Center

Intra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman

Goals and Objectives. Assessment Methods/Tools

A Change in Myocardial Preservation Strategies using the Quest Medical MPS 2 System

3/17/2016. Marginal Gains in Perfusion Utilizing a Dual Cardiotomy Reservoir. Theory of Marginal Gains

Congenital heart operations place extreme demands

10/18/2017. Pediatric Readiness. What you need to know. Renee Axdorff-Dickey B.S.C.C.P., M.B.A., FPP. Disclosures. I have no financial Disclosures.

How to maintain optimal perfusion during Cardiopulmonary By-pass. Herdono Poernomo, MD

The Novel Use of a Low Prime Modified Ultrafiltration Apparatus in a 13-kg Jehovah s Witness Patient: A Case Report

Major Aortic Reconstruction; Cerebral protection and Monitoring

Blood Management of the Cardiac Patient in the Postoperative Period

Case scenario V AV ECMO. Dr Pranay Oza

CPB safety is the avoidance of unnecessary incidents that result in adverse patient outcomes. These are mostly associated with:

Cardioplegia Circuit Products { ANTEGRADE}

Blood Transfusion and Heart Surgery at Alder Hey. Philip Arnold, Consultant Paediatric Cardiac Anaesthetist, Alder Hey Children s Hospital, Liverpool

Index. Note: Page numbers of article titles are in boldface type.

ISPUB.COM. Concepts Of Neonatal ECMO. D Thakar, A Sinha, O Wenker HISTORY PATIENT SELECTION AND ECMO CRITERIA

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

The Impact of Roller Pump vs. Centrifugal Pump on Homologous Blood Transfusion in Pediatric Cardiac Surgery

Steph ani eph ani Mi M ck i MD Cleveland Clinic

Simplifying Techniques and Goals to allow for Less Invasive Surgery

ECMO for cardiac arrest patients: Update 2017

Self-priming Hemodynamic Reservoir and Inline Flow Meter for a Cardiopulmonary Bypass Simulation

Thomas G. Wharton. Memorial Lecture. D. Scott Lawson American Academy of Cardiovascular Perfusion January 25, 2014

Cardioplegia Circuit Products { CARDIOPLEGIA ADAPTERS}

Rat Cardiopulmonary Bypass Model: Application of a Miniature Extracorporeal Circuit Composed of Asanguinous Prime

Modified Ultrafiltration After Congenital Heart Surgery: A Veno Venous Method Using a Dual-Lumen Hemodialysis Catheter

Monitoring Microemboli During Cardiopulmonary Bypass with the EDAC Quantifier

2. Langendorff Heart

Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease

Is the patient at risk for blood loss of 1000 mls? Avoid these Guidelines. Avoid these Guidelines. Yes. Yes. Yes. Yes. Yes

HYPOVOLEMIA AND HEMORRHAGE UPDATE ON VOLUME RESUSCITATION HEMORRHAGE AND HYPOVOLEMIA DISTRIBUTION OF BODY FLUIDS 11/7/2015

ECCO 2 Removal The Perfusionists Perspective

Nothing to Disclose. Severe Pulmonary Hypertension

IABP Timing & Fidelity. Pocket Reference Guide

Optimizing Blood ManagementTM

ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS

ECMO Primer A View to the Future

Clinical Evaluation of the Accuracy and Precision of the CDI 500 In-line Blood Gas Monitor With and Without Gas Calibration

Principles of cardiopulmonary bypass

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

Heinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania

Epidemiology of Heart Failure in Adults

Perfusion Techniques Toward Bloodless Pediatric Open Heart Surgery

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?

Why Old Blood is Bad. tales from the electronic perfusion record. Molly Marko, BS, BSE, CCP Geisinger Health System Danville, Pennsylvania

Mechanics of Cath Lab Support Devices

Evaluation of Biocompatible Cardiopulmonary Bypass Circuit Use During Pediatric Open Heart Surgery

The Coronary Baroreflex in Humans

Building The Foundation of a Great Cardiac Program Using Registries to Initiate and Sustain Improvement

Acid-base management during hypothermic CPB alpha-stat and ph-stat models of blood gas interpretation

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Solution for cardiac perfusion in viaflex plastic container

Kevin K. Nunnink Extracorporeal Membrane Oxygenation Program

Introduction to Cardiopulmonary Bypass. TSDA Boot Camp July 26-29, 2012 Chapel Hill, NC

The Role of ECMO in Thoracic Surgery. Matthew Hartwig, MD

ADULT OXYGENATORS CATALOGUE

Alternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia

Setting Up The Heart Room

Goal Directed Perfusion: theory, clinical results, and key rules

EVALUATION OF CONTEMPORARY OXYGENATOR PERFORMANCE

ECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit

The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization

MEDICAL EQUIPMENT II HEMODIALYSIS

A Dynamic Bubble Trap Reduces Microbubbles During Cardiopulmonary Bypass: A Case Study

Cardiac Surgery Jan-June 2017 The International Quality Improvement Collaborative (IQIC) experience.

Mechanics of Cath Lab Support Devices

AORTIC ROOT CANNULAE 8 RETROGRADE CARDIOPLEGIA CANNULA 10 CARDIOPLEGIA NEEDLE 11 CARDIOPLEGIA ADAPTERS 12 OSTIAL PERFUSION CANNULA 15

Presented by: Indah Dwi Pratiwi

Conventional vs. Goal Directed Perfusion (GDP) Management: Decision Making & Challenges

Perioperative Management of DORV Case

Blood Gases / Acid-Base

Comparison of Flow Differences amoiig Venous Cannulas

In Vitro Evaluation of the Medtronic Cardioplegia Safety System

Unrestricted. Dr ppooransari fellowship of perenatalogy

Heart transplantation is the gold standard treatment for

Adult Extracorporeal Life Support (ECLS)

When Cyanosis is the Norm. Steven M. Schwartz, MD, FRCPC Cardiac Critical Care Medicine The Hospital for Sick Children Toronto

Perfusion s Role in Blood Management Guidelines

Selective Heart, Brain and Body Perfusion in Open Aortic Arch Replacement

Conflicts of Interest

Mirsad Kacila*, Katrin Schäfer, Esad Subašić, Nermir Granov, Edin Omerbašić, Faida Kučukalić, Ermina Selimović-Mujčić

Preparing for Patients at High Risk of Transfusion

Transcription:

CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know Scott Lawson, CCP Carrie Striker, CCP Disclosure: Nothing to disclose Objectives: * Demonstrate how the cardiopulmonary bypass machine works and be able to help troubleshoot problems. * Explain some of the different techniques of cardiopulmonary bypass. I. Heart Lung Machine Brief Overview a. Review blood flow through the heart lung machine (Andropoulos, D. Anesthesia for Congenital Heart Disease. 2 nd Ed. 2010, p. 96) Page 1 of 7

II. Anatomy of the Pump a. Propulsion i. Arterial Pump 1. Roller Pump 2. Centrifugal Pump ii. Cardioplegia Pump iii. MUF Pump iv. Vent Pump(s) v. Field Sucker Pump (s) vi. Vacuum: Negative pressure on the venous line for drainage purposes b. Ventilation and Oxygenation i. Blender Oxygenation Fraction ii. Sweep Gas Ventilation iii. Exogenous CO 2 iv. Vaporizer Volatile anesthetics c. Monitoring i. Pressures: Arterial, Cardioplegia, MUF ii. Blood Flow: Pump Display, Doppler reading iii. Saturations: Venous, Arterial, Somatic/Cerebral, Flank/Renal iv. Temperatures: Arterial, Venous, Cardioplegia, MUF 1. Temperature Control: a. Heater Cooler v. Air bubble Protection: Bubble Detector, Level Detector vi. Blood Gas/Electrolyte/Hemoglobin and Hematocrit/ACT/Whole Blood Hemostasis Testing: Point of Care Blood Gas and Activated Clotting Time machine, In-line monitoring (CDI, Saturation/Hematocrit), TEG or ROTEM d. Disposables i. Venous Reservoir ii. Oxygenator 1. Integrated Arterial Line Filter 2. Standalone Arterial Line Filter iii. Arterial Venous Loop Size iv. Arterial Raceway size for Roller Pump v. Tubing vi. Cardioplegia vii. Hemoconcentrator viii. Cannulae e. Route of Blood Flow through the actual Heart Lung Machine Page 2 of 7

III. Perfusionist Pre-Bypass Considerations a. Selection of Disposables i. Calculation of Cardiac Output (CO) using patient height, weight and BSA (Appendix A) 1. Cardiac Index = 1.8 3.0 L/min/m 2 a. Determine oxygenator, venous reservoir, and arterial venous loop based on CO, cardiac lesion, suspected patient physiology and proposed surgical repair (see Appendix B) b. Priming of the Pump i. Fluids to clear prime CPB circuit: Crystalloids: Plasmalyte, Normasol ii. Determine clear prime volume based on prime volume of disposables chosen iii. Calculation of Estimated Blood Volume (EBV) and Post-dilutional HCT EBV: Weight (kg) 40: 65mL/kg Weight (kg) 20: 75mL/kg Weight (kg) 10: 85mL/kg Weight (kg) 4: 90mL/kg Weight (kg) 1: 100mL/kg 1. Determine necessary amount of prbcs to maintain appropriate HCT iv. Colloid osmotic pressure 1. FFP for coagulation factors and maintenance of colloid osmotic pressure 2. Albumin v. Buffer prime: sodium bicarbonate and/ or pre-buf vi. Drugs: heparin, antibiotics, possible steroids, cardioplegia solution (depolarizing/intracellular), mannitol, antifibrinolytics IV. Conduct of CPB: What is the Perfusionist looking for? a. Initiation of Flow i. Appropriate Cannula Placement 1. Arterial: looking for appropriate arterial pressure to confirm cannula placement. Page 3 of 7

a. High pressure spike may indicate placement of the aortic cannula in a false lumen and/or possible dissection. 2. Venous: enough return to get reasonable cardiac output as determined by perfusion adequacy indicators ii. Oxygenation 1. Look for blood color difference between arterial and venous to ensure oxygenator and oxygen source is working. Blood gas confirmation if necessary. b. Peri-CPB i. Maintenance of Physiology 1. Following venous, cerebral and renal saturations a. If low, may increase flow, give prbcs, ph-stat v. alphastat gas strategy, increase MAP 2. Manipulation of Patient Pressures a. Maintenance of calculated cardiac output i. Specific indices ii. Depends on patient s physiology iii. Perfusion adequacy markers iv. Appropriate saturations 3. Look for development of metabolic acidosis (blood gasses or inline monitoring) a. Increase flow, give prbcs, decrease temperature, alter gas strategy (ph-stat v. alpha stat) i. ph-stat: temperature corrected blood gases requiring exogenous CO 2 ii. alpha-stat: blood gases measured at 37ºC ii. Cardioplegic arrest 1. Antegrade: promote flow down the coronaries by slightly increasing the cardioplegia pump flow rate and pressure to gently close the aortic valve if not obtaining an arrest 2. Retrograde: monitor coronary sinus pressures 3. Re-dose: follow EKG or field movement for reemergence of activity c. Coming off CPB: i. Clamp venous line to begin loading the patient s heart with volume 1. Use MAP, CVP and heart appearance as guide ii. Drop flow in increments to transition flow responsibilities to the heart iii. Modified Ultrafiltration (MUF) 1. Arterial to Venous MUF: ensuring negative pressure is not exerted on the arterial line causing air cavitation at the aortic cannula Page 4 of 7

2. Use MAP, CVP, saturations and heart appearance as guide for fluid removal 3. End-points of MUF: increase Hgb, decrease in CVP, increase in MAP V. Conduct of Bypass: How can the anesthesiologist help? a. Initiation of Flow i. Before full flow: 1. Anesthesiologist: maintain oxygenation and ventilation b. Peri-CPB: i. Balance of Pressures: 1. Lowering the Pressure a. Anesthesiologist: Vasodilators (nipride, nitroglycerine, nicardipine) b. Perfusionist: Volatile Anesthetic (Iso, sevo), dropping flow, ph stat strategy 2. Increasing the Pressure a. Anesthesiologist: Pressors b. Perfusionist: Increasing flow, phenylephrine, alpha stat gas strategy ii. Metabolic Augmentation of Flow 1. Acidosis a. Anesthesiologist: Drop MAPs to increase flow, inspect surgical field for obvious mechanical deviations, communication with perfusionist to surgeon b. Perfusionist: Increase Flow, increase oxygenation, give red blood cells to increase Hgb, alter gas strategy (MAPCA manipulation), investigate cannula placement, decrease temperature c. Coming off CPB: i. Oxygenation and Ventilation Transition from pump to patient ii. MUF: Communicate with Perfusionist regarding pressure manipulation iii. Medications iv. Volume: Help from the pump, cell saver Page 5 of 7

Appendix A: Calculation of Cardiac Output on Cardiopulmonary Bypass BSA ( Weight Height) 3636 2 2 CO 2500( ml/ min/ m ) BSA( m ) Page 6 of 7

Appendix B: Determining Cardiopulmonary Bypass Equipment Selection CARDIOPULMONARY BYPASS PROCEDURE Disposable Perfusion Supplies and Flow Ranges Oxygenator+ Capiox RX 05 w/ Xcoating Lilliput 2 w/ Phosphorylcholine inert surface Optimin Optima Equipment Selection Approximate blood flow cc/min A-V loop Max flow: 1500 recommend.) 3/16 x ¼ up to 1000 ¼ x ¼ up to 1400 Max flow: 2300 recommend.) to 3300 (A.A.M.I Standard) ¼ x ¼ up to 1400 ¼ x 3/8 up to 3000 Max flow: 5000 recommend.) 3/8 x 3/8 up to 5000 Flow over 5000 recommend.) 3/8 x 3/8 up to 5000 3/8 x ½ over 5000 Full Flow = 1061 ml/min Tubing + Pump raceway Infant pack using primarily ¼ 3/16 @ < 600 or ¼ @ > 600 Infant pack using primarily ¼ ¼ @ <2500 or 3/8 @ > 2500 Pediatric/adult pack using primarily 3/8 3/8 @ < 5000 Pediatric/adult pack using primarily 3/8 3/8 @ <5000 or ½ >5000 Bubble trap + Cardiotomy /Venous Reservoir & safe operating level (SOL) Cardioplegia set + Ventricular venting 50 cc 1100 cc capacity SOL = 50 cc Custom Infant CSC14 4:1 w/ Buretrol ¼ w/ valve (vacuum relief check valve may be to accommodate high flow) 50 cc 1800 cc capacity SOL = 100 cc Custom Infant CSC14 4:1 w/ Buretrol ¼ w/ valve (vacuum relief check valve may be to accommodate high flow) 150 cc 3000 cc capacity SOL = 200 cc Custom Adult CSC14 4:1 w/ 2 Buretrols ¼ w/ valve or 3/8 collapsible 150 cc 3000 cc capacity SOL = 400 cc Custom Adult CSC14 4:1 w/ 2 Buretrols ¼ w/ valve or 3/8 collapsible Hemoconcentrator + Asahi PAN 03 Asahi PAN 06 Asahi PAN 06 Asahi PAN 06 Approx. circuit 400 cc 700 cc 1500 cc 1800 cc Page 7 of 7